Chu Dijon-Bourgogne
Dijon 21079
6 studies enrolling now · 14 studies all time
What they study most
AVM, Advanced Cutaneous Squamous Cell Carcinoma, Alopecia Areata, Aortic Diseases, Arteriovenous Malformations, BAVM, Carotid Artery Diseases, Community-acquired Pneumonia, Influenza, COVID-19, Insomnia, Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome, Peripheral Arterial Diseases, Portal Hypertension
Studies at this site
- Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib — Recruiting now
- Intervascular Post-Market Clinical Follow-Up (PMCF) Registry — Recruiting now
- ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS) — Recruiting now
- Treatment of Brain AVMs (TOBAS) Study — Recruiting now
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
- Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia — Running, not enrolling
- The BD Liverty™ TIPS Stent Graft Study — Running, not enrolling
- A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed
- Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease — Starting soon
- A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) — Completed
- CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
- Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma — Completed
- Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1) — Completed
- Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients — Stopped early